Literature DB >> 17701153

[Chorea. Causes, diagnosis, and therapy].

C M Kosinski1, B Landwehrmeyer.   

Abstract

The differential diagnosis of chorea includes a growing number of rare diseases. This article gives hints on clinical differences and possible laboratory investigations which may help to identify the underlying disease. The majority of hereditary chorea cases are caused by Huntington's disease. Different courses of disease can be distinguished depending on age at disease onset. The diagnosis can be confirmed genetically. Predictive testing is also possible but should be applied with caution only following internationally accepted guidelines. Our knowledge about treatment of chorea is limited, and studies have focused on the use of neuroleptics only. Their value is often outweighed by serious side effects. All efforts to find disease-modifying therapies for Huntington's disease had negative outcomes so far. To face these therapeutic limitations, the European Huntington's Disease Network was formed as a platform supporting the development and undertaking of clinical studies in Huntington's disease to improve care for these patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17701153     DOI: 10.1007/s00115-007-2330-0

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  11 in total

Review 1.  [Huntington chorea. Animal models reveal new hypotheses for pathophysiology and therapy].

Authors:  C M Kosinski; J H Cha; A B Young; M Schwarz
Journal:  Nervenarzt       Date:  1999-10       Impact factor: 1.214

2.  Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study.

Authors:  Anne-Catherine Bachoud-Lévi; Véronique Gaura; Pierre Brugières; Jean-Pascal Lefaucheur; Marie-Françoise Boissé; Patrick Maison; Sophie Baudic; Maria-Joao Ribeiro; Catherine Bourdet; Philippe Remy; Pierre Cesaro; Philippe Hantraye; Marc Peschanski
Journal:  Lancet Neurol       Date:  2006-04       Impact factor: 44.182

Review 3.  [Laboratory diagnosis of hyperkinetic movement disorders in adulthood].

Authors:  U Laubis-Herrmann; H Topka
Journal:  Nervenarzt       Date:  2002-02       Impact factor: 1.214

Review 4.  Pharmacological management of Huntington's disease: an evidence-based review.

Authors:  Raphael M Bonelli; Gregor K Wenning
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

5.  International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease.

Authors: 
Journal:  J Med Genet       Date:  1994-07       Impact factor: 6.318

6.  [Progress in molecular chorea diagnosis. McLeod syndrome and chorea acanthocytosis].

Authors:  A Danek
Journal:  Nervenarzt       Date:  2002-06       Impact factor: 1.214

7.  Hypokinesia in Huntington's disease.

Authors:  J P van Vugt; B J van Hilten; R A Roos
Journal:  Mov Disord       Date:  1996-07       Impact factor: 10.338

Review 8.  Huntington's disease and other choreas.

Authors:  N Quinn; A Schrag
Journal:  J Neurol       Date:  1998-11       Impact factor: 4.849

9.  [Psychiatric and ethical aspects of genetic diagnosis exemplified by Huntington chorea].

Authors:  U Meincke; Ch Kosinski; K Zerres; G Maio
Journal:  Nervenarzt       Date:  2003-05       Impact factor: 1.214

10.  Assessment of in vitro and in vivo mitochondrial function in Friedreich's ataxia and Huntington's disease.

Authors:  Anthony Schapira; Raffaele Lodi
Journal:  Methods Mol Biol       Date:  2004
View more
  1 in total

1.  [Choreatic syndrome at 79 years old: late manifestation of Huntington's chorea].

Authors:  I Vachalova; V Golden; J Großkopf; J G Heckmann
Journal:  Nervenarzt       Date:  2013-12       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.